← Leaderboards
Jennifer L. Guerriero
Dana-Farber Cancer Inst
$2,031,971
Attributed
$2,031,971
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $486.6K · FY2013–25$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,031,971 · 2
By mechanism
R37$1,866,725 · 1
F32$165,246 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Geoffrey I Shapiro$18,639,470
- Donald W. Kufe$50,160,456
- Rani E George$9,003,170
- Kornelia Polyak$28,582,691
- Brian Matthew Wolpin$8,665,523
Others in their field
Top investigators on “Immune”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmuneIn VivoMonocyteTumorCell SurvivalMacrophageIn VitroMediatingResponseResistanceTumor GrowthPhenotypeCellsNeoplasm MetastasisCancer TherapyChemotherapyCancer PatientClinical TrialsCytotoxic T-LymphocytesBreast OncologyCellular ImagingBreast Cancer TreatmentAngiogenesisDependence
Grant awards (7)
Immunometabolic pathways enabled by PARP inhibition in breast cancer$486,593
R37 · FY2025 · CA · contact PI
Immunometabolic pathways enabled by PARP inhibition in breast cancer$445,716
R37 · FY2024 · CA · contact PI
Immunometabolic pathways enabled by PARP inhibition in breast cancer$463,884
R37 · FY2023 · CA · contact PI
Immunometabolic pathways enabled by PARP inhibition in breast cancer$470,532
R37 · FY2022 · CA · contact PI
Harnessing anti-tumor macrophages for cancer therapy$57,962
F32 · FY2015 · CA · contact PI
Harnessing anti-tumor macrophages for cancer therapy$55,094
F32 · FY2014 · CA · contact PI
Harnessing anti-tumor macrophages for cancer therapy$52,190
F32 · FY2013 · CA · contact PI